Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β‐adrenergic stimulation
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Sudden cardiac death caused by ventricular arrhythmias is a disastrous event, especially when it occurs in young individuals. Among the five major arrhythmogenic disorders occurring in the absence of a structural heart disease is catecholaminergic polymorphic ventricular tachycardia (CPVT), which is a highly lethal form of inherited arrhythmias. Our study focuses on the autosomal recessive form of the disease caused by the missense mutation D307H in the cardiac calsequestrin gene, CASQ2. Because CASQ2 is a key player in excitation contraction coupling, the derangements in intracellular Ca 2+ handling may cause delayed afterdepolarizations (DADs), which constitute the mechanism underlying CPVT. To investigate catecholamine‐induced arrhythmias in the CASQ2 mutated cells, we generated for the first time CPVT‐derived induced pluripotent stem cells (iPSCs) by reprogramming fibroblasts from skin biopsies of two patients, and demonstrated that the iPSCs carry the CASQ2 mutation. Next, iPSCs were differentiated to cardiomyocytes (iPSCs‐CMs), which expressed the mutant CASQ2 protein. The major findings were that the β‐adrenergic agonist isoproterenol caused in CPVT iPSCs‐CMs (but not in the control cardiomyocytes) DADs, oscillatory arrhythmic prepotentials, after‐contractions and diastolic [Ca 2+]i rise. Electron microscopy analysis revealed that compared with control iPSCs‐CMs, CPVT iPSCs‐CMs displayed a more immature phenotype with less organized myofibrils, enlarged sarcoplasmic reticulum cisternae and reduced number of caveolae. In summary, our results demonstrate that the patient‐specific mutated cardiomyocytes can be used to study the electrophysiological mechanisms underlying CPVT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“Indeed, since the seminal breakthrough of generating iPSCs [36, 37], several patient-specific iPSCs lines were developed for a variety of diseases, including neurodegenerative diseases and metabolic disorders [38, 39].”
BackgroundSoldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549 · cited 1×
“Indeed, since the seminal breakthrough of generating iPSCs [36, 37], several patient-specific iPSCs lines were developed for a variety of diseases, including neurodegenerative diseases and metabolic disorders [38, 39].”
BackgroundPriori, S. G., Napolitano, C., Tiso, N., Memmi, M., Vignati, G., Bloise, R., Sorrentino, V., & Danieli, G. A. (2001) · Circulation · doi:10.1161/01.cir.103.2.196 · Cited by 1,378 · cited 3×
“[1] identified mutations in the cardiac ryanodine receptor (RyR2) underlying an autosomal dominant form of CPVT.”
BackgroundInfluentialPatient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251 · cited 1×
“Recently several groups reported on the generation of patient-specific iPSCs from patients affected by long-QT syndrome type 1 [9], long-QT syndrome type 2 [10] and Timothy syndrome [11], and showed the capacity of these cells to give rise to functional cardiomyocytes that display the electrophysiological characterist…”
BackgroundModelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049 · cited 1×
“Recently several groups reported on the generation of patient-specific iPSCs from patients affected by long-QT syndrome type 1 [9], long-QT syndrome type 2 [10] and Timothy syndrome [11], and showed the capacity of these cells to give rise to functional cardiomyocytes that display the electrophysiological characterist…”
BackgroundUsing induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., & Dolmetsch, R. E. (2011) · Nature · doi:10.1038/nature09855 · Cited by 677 · cited 2×
“Recently several groups reported on the generation of patient-specific iPSCs from patients affected by long-QT syndrome type 1 [9], long-QT syndrome type 2 [10] and Timothy syndrome [11], and showed the capacity of these cells to give rise to functional cardiomyocytes that display the electrophysiological characterist…”
BackgroundInduced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-1075 · Cited by 676
Lahat, H., Pras, E., Olender, T., Avidan, N., Ben-Asher, E., Man, O., Levy-Nissenbaum, E., Khoury, A., Lorber, A., Goldman, B., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/324565 · Cited by 655
Self-citationGeneration of pluripotent stem cells from patients with type 1 diabetes
Maehr, R., Chen, S., Snitow, M., Ludwig, T., Yagasaki, L., Goland, R., Leibel, R. L., & Melton, D. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906894106 · Cited by 568 · cited 1×
“Indeed, since the seminal breakthrough of generating iPSCs [36, 37], several patient-specific iPSCs lines were developed for a variety of diseases, including neurodegenerative diseases and metabolic disorders [38, 39].”
BackgroundAction potentials, afterpotentials, and arrhythmias.
Cranefield, P. F. (1977) · Circulation Research · doi:10.1161/01.res.41.4.415 · Cited by 475 · cited 1×
“We report here for the first time that in addition to the familiar DADs occurring in CPVT mutant cardiomyocytes in response to adrenergic stimulation [1, 3, 5], isoproterenol also caused arrhythmogenic depolarizing oscillatory prepotentials, which were originally described in cardiac muscle by Bozler in 1942 [29, 30].”
BackgroundKnollmann, B. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29128 · Cited by 444 · cited 3×
“The ultrastructural analysis also demonstrated that compared with control, CPVT cardiomyocytes have fewer caveolae [24], which participate in a variety of cellular functions such as signal transduction and Ca(2) homeostasis [26–28].”
BackgroundCaveolae as Organizers of Pharmacologically Relevant Signal Transduction Molecules
Patel, H. H., Murray, F., & Insel, P. A. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121506.124841 · Cited by 439
Somers, A., Jean, J.-C., Sommer, C. A., Omari, A., Ford, C. C., Mills, J. A., Ying, L., Sommer, A. G., Jean, J. M., Smith, B. W., et al. (2010) · Stem Cells · doi:10.1002/stem.495 · Cited by 423
Progress toward the clinical application of patient-specific pluripotent stem cells
Kiskinis, E., & Eggan, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40553 · Cited by 339 · cited 1×
“Patient-specific iPSCs can provide useful platforms for the discovery of unprecedented insights into disease mechanisms, as well as new drugs [35].”
BackgroundPostma, A. V., Denjoy, I., Kamblock, J., Alders, M., Lupoglazoff, J.-M., Vaksmann, G., Dubosq-Bidot, L., Sebillon, P., Mannens, M. M. A. M., Guicheney, P., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028993 · Cited by 304 · cited 1×
“These findings, which still need to be established in a larger number of preparations and different clones, are in agreement with studies reporting a lower resting heart rate among CPVT patients [21, 22].”
Resultdi Barletta, M. R., Viatchenko-Karpinski, S., Nori, A., Memmi, M., Terentyev, D., Turcato, F., Valle, G., Rizzi, N., Napolitano, C., Gyorke, S., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.623793 · Cited by 207
Terentyev, D., Nori, A., Santoro, M., Viatchenko-Karpinski, S., Kubalova, Z., Gyorke, I., Terentyeva, R., Vedamoorthyrao, S., Blom, N. A., Valle, G., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000220647.93982.08 · Cited by 196
Song, L., Alcalai, R., Arad, M., Wolf, C. M., Toka, O., Conner, D. A., Berul, C. I., Eldar, M., Seidman, C. E., & Seidman, J. G. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31080 · Cited by 187 · cited 1×
“This key phenomenon is consistent with a similar increase in diastolic [Ca(2) ]i demonstrated in paced cardiomyocytes from mutant mouse with deficient CASQ2, in the presence of isoproterenol [7].”
ResultLiu, J., Fu, J. D., Siu, C. W., & Li, R. A. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0549 · Cited by 186
Dolnikov, K., Shilkrut, M., Zeevi-Levin, N., Gerecht-Nir, S., Amit, M., Danon, A., Itskovitz-Eldor, J., & Binah, O. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0036 · Cited by 184 · cited 5×
“2-CMs which were previously reported not to express the protein [16, 19, 20].”
BackgroundMethodResultInfluentialSelf-citationCaveolae, ion channels and cardiac arrhythmias
Balijepalli, R. C., & Kamp, T. J. (2008) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2009.01.012 · Cited by 175 · cited 6×
“5), pacemaker channels (HCN4) and the Na /Ca(2) exchanger (NCX1) [26].”
BackgroundInfluentialAbnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin
Viatchenko-Karpinski, S., Terentyev, D., Györke, I., Terentyeva, R., Volpe, P., Priori, S. G., Napolitano, C., Nori, A., Williams, S. C., & Györke, S. (2004) · Circulation Research · doi:10.1161/01.res.0000115944.10681.eb · Cited by 171 · cited 4×
“We report here for the first time that in addition to the familiar DADs occurring in CPVT mutant cardiomyocytes in response to adrenergic stimulation [1, 3, 5], isoproterenol also caused arrhythmogenic depolarizing oscillatory prepotentials, which were originally described in cardiac muscle by Bozler in 1942 [29, 30].”
BackgroundInfluentialGermanguz, I., Sedan, O., Zeevi‐Levin, N., Shtrichman, R., Barak, E., Ziskind, A., Eliyahu, S., Meiry, G., Amit, M., Itskovitz‐Eldor, J., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00996.x · Cited by 160 · cited 3×
“In the present study, similar to previous immunofluorescence staining findings in cardiomyocytes generated from ESCs (recombinant CASQ2) [20] and iPSCs [17], we found that the staining pattern of CASQ2 is different from adult mouse ventricular myocytes [5, 6] in which CASQ2 is co-localized with the Z bands.”
BackgroundMethodResultSelf-citationGherghiceanu, M., Barad, L., Novak, A., Reiter, I., Itskovitz-Eldor, J., Binah, O., & Popescu, L. M. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01417.x · Cited by 155 · cited 3×
“As previously reported in cardiomyocytes derived from ESCs and iPSCs [18, 25], T-tubules were not observed in control and CPVT iPSCs-CMs, which is explained by the findings that T tubules formation occurs relatively late in mammalian cardiomyocytes development.”
BackgroundMethodResultSelf-citationRizzi, N., Liu, N., Napolitano, C., Nori, A., Turcato, F., Colombi, B., Bicciato, S., Arcelli, D., Spedito, A., Scelsi, M., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.171660 · Cited by 153 · cited 1×
“Ultrastructural assessment of CPVT cardiomyocytes showed small expansion of the SR cisternae, as previously reported in a mouse model of CPVT with a deficient cardiac calsequestrin [5, 23, 24].”
BackgroundTHE INITIATION OF IMPULSES IN CARDIAC MUSCLE
Bozler, E. (1943) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1943.138.2.273 · Cited by 134 · cited 1×
“We report here for the first time that in addition to the familiar DADs occurring in CPVT mutant cardiomyocytes in response to adrenergic stimulation [1, 3, 5], isoproterenol also caused arrhythmogenic depolarizing oscillatory prepotentials, which were originally described in cardiac muscle by Bozler in 1942 [29, 30].”
BackgroundMolecular and Electrophysiological Bases of Catecholaminergic Polymorphic Ventricular Tachycardia
MOHAMED, U., NAPOLITANO, C., & PRIORI, S. G. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00766.x · Cited by 118 · cited 2×
“Nevertheless, as recently stated by Priori’s group [34], ‘the chance of discovering new strategies to treat CPVT is tightly dependent upon the progress in understanding the molecular and the electrophysiological determinants of the CPVT phenotype and of the relationships between intracellular Ca(2) regulation and arrh…”
BackgroundLiu, J., Lieu, D. K., Siu, C. W., Fu, J.-D., Tse, H.-F., & Li, R. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00060.2009 · Cited by 109 · cited 3×
“In the present study, similar to previous immunofluorescence staining findings in cardiomyocytes generated from ESCs (recombinant CASQ2) [20] and iPSCs [17], we found that the staining pattern of CASQ2 is different from adult mouse ventricular myocytes [5, 6] in which CASQ2 is co-localized with the Z bands.”
BackgroundResultNovak, A., Shtrichman, R., Germanguz, I., Segev, H., Zeevi-Levin, N., Fishman, B., Mandel, Y.-E., Barad, L., Domev, H., Kotton, D., et al. (2010) · Cellular Reprogramming · doi:10.1089/cell.2010.0027 · Cited by 77 · cited 2×
“2, from biopsies HDF7, HDF12, HDF3 and HDF5, respectively) and hair keratinocytes (clone KTR13 from the KTR biopsy) [12], using the STEMCCA Cassette (a single lentiviral vector containing the four factors:”
BackgroundMethodSelf-citationCatecholaminergic Polymorphic Ventricular Tachycardia from Bedside to Bench and Beyond
Katz, G., Arad, M., & Eldar, M. (2008) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2008.09.002 · Cited by 70 · cited 1×
“These findings, which still need to be established in a larger number of preparations and different clones, are in agreement with studies reporting a lower resting heart rate among CPVT patients [21, 22].”
ResultDirksen, W., Lacombe, V., Chi, M., Kalyanasundaram, A., Viatchenko‐Karpinski, S., Terentyev, D., Zhou, Z.-X., Vedamoorthyrao, S., Li, N., Chiamvimonvat, N., et al. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.002 · Cited by 62
T-tubule formation in cardiacmyocytes: two possible mechanisms?
Maio, A. D., Karko, K. L., Snopko, R. M., Mejía-Alvarez, R., & Franzini‐Armstrong, C. (2007) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-007-9121-x · Cited by 59 · cited 1×
“As previously reported in cardiomyocytes derived from ESCs and iPSCs [18, 25], T-tubules were not observed in control and CPVT iPSCs-CMs, which is explained by the findings that T tubules formation occurs relatively late in mammalian cardiomyocytes development.”
ResultSedan, O., Dolnikov, K., Zeevi-Levin, N., Leibovich, N., Amit, M., Itskovitz-Eldor, J., & Binah, O. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0777 · Cited by 46
Self-citationThe Fifteen Years of Discoveries That Shaped Molecular Electrophysiology: Time for Appraisal
Priori, S. G. (2010) · Circulation Research · doi:10.1161/circresaha.110.226811 · Cited by 39 · cited 1×
“Although DADs were described in vitro and in vivo, the demonstration that they were responsible for arrhythmogenesis in humans was largely a consequence of genetic research [40].”
Kalyanasundaram, A., Bal, N. C., Franzini‐Armstrong, C., Knollmann, B. C., & Periasamy, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053892 · Cited by 31 · cited 1×
“In the present study, similar to previous immunofluorescence staining findings in cardiomyocytes generated from ESCs (recombinant CASQ2) [20] and iPSCs [17], we found that the staining pattern of CASQ2 is different from adult mouse ventricular myocytes [5, 6] in which CASQ2 is co-localized with the Z bands.”
ResultKim, E. M., Choy, Y. Q., & Vassalle, M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0382 · Cited by 24 · cited 4×
“In contrast to DADs that follow the action potential and therefore appear during the early diastolic depolarization, oscillatory prepotentials are defined as diastolic voltage oscillations, which appear during the late diastolic depolarization [31, 32].”
BackgroundInfluential
Cited by
Calcium Signaling and Cardiac Arrhythmias
Landstrom, A. P., Dobrev, D., & Wehrens, X. H. T. (2017) · Circulation Research · doi:10.1161/circresaha.117.310083 · Cited by 568
Karakikes, I., Ameen, M., Termglinchan, V., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.117.305365 · Cited by 478
Induced pluripotent stem cells: the new patient?
Bellin, M., Marchetto, M. C., Gage, F. H., & Mummery, C. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3448 · Cited by 431
Kamakura, T., Makiyama, T., Sasaki, K., Yoshida, Y., Wuriyanghai, Y., Chen, J., Hattori, T., Ohno, S., Kita, T., Horie, M., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-0987 · Cited by 295
Translation of Human-Induced Pluripotent Stem Cells
Sayed, N., Liu, C., & Wu, J. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.083 · Cited by 279
Metadata
- Authors
- Novak, A., Barad, L., Zeevi‐Levin, N., Shick, R., Shtrichman, R., Lorber, A., Itskovitz‐Eldor, J., & Binah, O.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2012-02-28
- Volume
- 16
- Issue
- 3
- Pages
- 468-482
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2106854002
- Cited by
- 177
- References
- 37
- FWCI
- 12.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.